arrow
L

Leonard B. Saltz

Memorial Sloan Kettering Cancer Center
H指数:144
被引数:8.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-derived external control arms

转移性结直肠癌随机试验中基于ARCAD衍生外部对照臂的总体生存期可重复性

2026-08-220
PRE
Does Radiation Boost Dose Affect Organ Preservation Rates? A Secondary Analysis of the Organ Preservation in Patients With Rectal Adenocarcinoma Trial

辐射助推剂量是否影响器官保留率?对直肠腺癌患者器官保留试验的二次分析

2026-05-150
PRE
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case report

对转移性黏液性尾部肠囊肿腺癌对吉西他滨和放射治疗的敏感性:一篇病例报告

2025-12-190
OAAI
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study

随着奥沙利铂为基础的化疗联合靶向药物,转移性结直肠癌的生存率随时间推移呈逐年改善:一项ARCAD数据库研究

2025-10-020
OAAI
Development of Second Malignancies Following Chemotherapy with or without Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer

局部晚期直肠癌治疗中,化疗联合或不联合放疗后第二恶性肿瘤的发展

2025-07-190
PRE
Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

接受全直肠系膜切除术或选择性观察等待策略治疗的总新辅助治疗患者的生存情况:CAO/ARO/AIO-12和OPRA随机II期试验的合并分析

2025-01-012
PRE
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait
2024-11-181
PRE
ASO Visual Abstract: Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait-Comparison of Intersphincteric Resection Versus Abdominoperineal Resection
2024-11-040
PRE
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
2024-11-011
PRE
Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection
2024-10-122
PRE
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials

放化疗加诱导或巩固化疗作为局部晚期直肠癌的总新辅助治疗: CAO/ARO/AIO-12和OPRA随机2期试验的汇总分析

2024-10-010
PRE
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy
2024-09-271
PRE
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis

经全身治疗的结直肠癌肝转移的预后价值: ARCAD汇总分析

2024-08-011
PRE
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer
2024-07-014
OA
Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy
2024-06-270
PRE
Colon Cancer, Version 3.2024
2024-06-0120
OA
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with Chemoradiation
2024-04-091
OA